A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Yale University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute